Berg Jonathan S, Agrawal Pankaj B, Bailey Donald B, Beggs Alan H, Brenner Steven E, Brower Amy M, Cakici Julie A, Ceyhan-Birsoy Ozge, Chan Kee, Chen Flavia, Currier Robert J, Dukhovny Dmitry, Green Robert C, Harris-Wai Julie, Holm Ingrid A, Iglesias Brenda, Joseph Galen, Kingsmore Stephen F, Koenig Barbara A, Kwok Pui-Yan, Lantos John, Leeder Steven J, Lewis Megan A, McGuire Amy L, Milko Laura V, Mooney Sean D, Parad Richard B, Pereira Stacey, Petrikin Joshua, Powell Bradford C, Powell Cynthia M, Puck Jennifer M, Rehm Heidi L, Risch Neil, Roche Myra, Shieh Joseph T, Veeraraghavan Narayanan, Watson Michael S, Willig Laurel, Yu Timothy W, Urv Tiina, Wise Anastasia L
Departments of Genetics and
Divisions of Newborn Medicine and.
Pediatrics. 2017 Feb;139(2). doi: 10.1542/peds.2016-2252. Epub 2017 Jan 17.
The rapid development of genomic sequencing technologies has decreased the cost of genetic analysis to the extent that it seems plausible that genome-scale sequencing could have widespread availability in pediatric care. Genomic sequencing provides a powerful diagnostic modality for patients who manifest symptoms of monogenic disease and an opportunity to detect health conditions before their development. However, many technical, clinical, ethical, and societal challenges should be addressed before such technology is widely deployed in pediatric practice. This article provides an overview of the Newborn Sequencing in Genomic Medicine and Public Health Consortium, which is investigating the application of genome-scale sequencing in newborns for both diagnosis and screening.
基因组测序技术的迅速发展已将基因分析成本降低到一定程度,以至于基因组规模测序在儿科护理中广泛应用似乎是可行的。对于表现出单基因疾病症状的患者,基因组测序提供了一种强大的诊断方式,也为在健康状况发展之前进行检测提供了机会。然而,在这种技术广泛应用于儿科实践之前,许多技术、临床、伦理和社会挑战都需要得到解决。本文概述了基因组医学与公共卫生联盟中的新生儿测序项目,该项目正在研究基因组规模测序在新生儿诊断和筛查中的应用。